Page 1581 - Williams Hematology ( PDFDrive )
P. 1581

1556           Part XI:  Malignant Lymphoid Diseases                                                                                                                                    Chapter 93:  Hairy Cell Leukemia         1557





                                                                             10 3
                                   1023                                         G1 0.0%  G2 3.1%

                                                                             10 2
                                                            Monos
                                                            1.8%
                                 SS Lin                                    CD19-ECD  10 1


                                                                             10 0
                                                                                G3    G4
                                        Blasts                                         0.8%
                                        0.0%               Lymphs               96.1%
                                                           33.7%
                                   0
                                            10 0  10 1   10 2  10 3                  10 0  10 1  10 2  10 3
                                                CD45-PC7                                CD20-FITC
                                   10 3                                      10 3
                                      F1    F2                                  G1    G2
                                       1.9%  2.7%                                0.5%  2.6%
                                            O
                                   10 2      2.7%                            10 2
                                 CD25-PC5  10 1                            CD19-ECD  10 1



                                   10 0                                      10 0
                                      F3    F4                                  G3    G4
                                       95.0%  0.4%                              95.8%  1.1%
                                            10 0  10 1  10 2  10 3                   10 0  10 1   10 2  10 3
                                               CD19-ECD                                  CD103-FITC
                                    10 3                                     10 3
                                      D1     D2                                 D1    D2
                                       8.3%  2.9%                                8.9%  2.9%
                                    10 2                                     10 2
                                  CD11c-PE  10 1                           CD123-PE  10 1



                                    10 0                                     10 0
                                      D3     D4                                 D3    D4
                                       88.6%  0.2%                              87.9%  0.3%
                                            10 0  10 1  10 2  10 3                    10 0  10 1  10 2  10 3
                                               CD19-ECD                                  CD19-ECD
                                    10 3                                     10 3
                                       F1    F2                                 C1    C2
                                       76.5%  0.1%                               0.1%  5.5%
                                    10 2                                     10 2
                                  CD27-PC5  10 1                           Lambda-PE  10 1  AJ 0.1%



                                    10 0                                     10 0               AK
                                       F3    F4                                 C3    C4         13.9%
                                       20.3%  3.0%                               81.9%  12.6%
                                            10 0  10 1  10 2  10 3                    10 0  10 1  10 2  10 3
                                               CD19-ECD                                 Kappa-FITC
               Figure 93–1.  Hairy cell leukemia (HCL) immunophenotypic profiling should be performed using multiparametric flow cytometry analysis. Both
               blood and hemodilute marrow aspirates should be analyzed regardless of the number of leukemic cells seen on morphologic review of slides.
               Because of a very characteristic immunophenotype, definitive diagnosis of HCL can be rendered based on flow cytometric data even with a very low
               number of leukemic cells. As a result of their complex surface projections, hairy cells demonstrate moderate to high side scatter (SC) characteristics
               resulting in their shift on flow plots into the region typically occupied by monocytes. Hairy cells are positive for CD11c+, CD19+, CD20+, CD25+,
               CD103+, CD123+ and show κ light-chain restriction in this example. Hairy cells are negative for CD27−. Very rare cases of HCL may show positive
               staining for CD5 or CD10 antigens. It is important to note that while atypical, the expression of these antigens does not preclude a definitive diagnosis
               of HCL in cases with otherwise typical HCL immunophenotype.





          Kaushansky_chapter 93_p1553-1562.indd   1556                                                                  9/18/15   3:47 PM
   1576   1577   1578   1579   1580   1581   1582   1583   1584   1585   1586